Cargando…

Three families with ‘de novo’ m.3243A > G mutation

The m.3243A > G mutation is the most prevalent, disease-causing mitochondrial DNA (mtDNA) mutation. In a national cohort study of 48 families harbouring the m.3243A > G mutation, we identified three families in which the mutation appeared to occur sporadically within these families. In this re...

Descripción completa

Detalles Bibliográficos
Autores principales: de Laat, Paul, Janssen, Mirian C.H., Alston, Charlotte L., Taylor, Robert W., Rodenburg, Richard J.T., Smeitink, Jan A.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900294/
https://www.ncbi.nlm.nih.gov/pubmed/27331024
http://dx.doi.org/10.1016/j.bbacli.2016.04.007
_version_ 1782436604323823616
author de Laat, Paul
Janssen, Mirian C.H.
Alston, Charlotte L.
Taylor, Robert W.
Rodenburg, Richard J.T.
Smeitink, Jan A.M.
author_facet de Laat, Paul
Janssen, Mirian C.H.
Alston, Charlotte L.
Taylor, Robert W.
Rodenburg, Richard J.T.
Smeitink, Jan A.M.
author_sort de Laat, Paul
collection PubMed
description The m.3243A > G mutation is the most prevalent, disease-causing mitochondrial DNA (mtDNA) mutation. In a national cohort study of 48 families harbouring the m.3243A > G mutation, we identified three families in which the mutation appeared to occur sporadically within these families. In this report we describe these three families. Based on detailed mtDNA analysis of three different tissues using two different quantitative pyrosequencing assays with sensitivity to a level of 1% mutated mtDNA, we conclude that the m.3243A > G mutation has arisen de novo in each of these families. The symptomatic carriers presented with a variety of symptoms frequently observed in patients harbouring the m.3243A > G mutation. A more severe phenotype is seen in the de novo families compared to recent cohort studies, which might be due to reporting bias. The observation that de novo m.3243A > G mutations exist is of relevance for both diagnostic investigations and genetic counselling. Firstly, even where there is no significant (maternal) family history in patients with stroke-like episodes, diabetes and deafness or other unexplained organ dysfunction, the m.3243A > G mutation should be screened as a possible cause of the disease. Second, analysis of maternally-related family members is highly recommended to provide reliable counselling for these families, given that the m.3243A > G mutation may have arisen de novo.
format Online
Article
Text
id pubmed-4900294
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-49002942016-06-21 Three families with ‘de novo’ m.3243A > G mutation de Laat, Paul Janssen, Mirian C.H. Alston, Charlotte L. Taylor, Robert W. Rodenburg, Richard J.T. Smeitink, Jan A.M. BBA Clin Regular Article The m.3243A > G mutation is the most prevalent, disease-causing mitochondrial DNA (mtDNA) mutation. In a national cohort study of 48 families harbouring the m.3243A > G mutation, we identified three families in which the mutation appeared to occur sporadically within these families. In this report we describe these three families. Based on detailed mtDNA analysis of three different tissues using two different quantitative pyrosequencing assays with sensitivity to a level of 1% mutated mtDNA, we conclude that the m.3243A > G mutation has arisen de novo in each of these families. The symptomatic carriers presented with a variety of symptoms frequently observed in patients harbouring the m.3243A > G mutation. A more severe phenotype is seen in the de novo families compared to recent cohort studies, which might be due to reporting bias. The observation that de novo m.3243A > G mutations exist is of relevance for both diagnostic investigations and genetic counselling. Firstly, even where there is no significant (maternal) family history in patients with stroke-like episodes, diabetes and deafness or other unexplained organ dysfunction, the m.3243A > G mutation should be screened as a possible cause of the disease. Second, analysis of maternally-related family members is highly recommended to provide reliable counselling for these families, given that the m.3243A > G mutation may have arisen de novo. Elsevier 2016-04-29 /pmc/articles/PMC4900294/ /pubmed/27331024 http://dx.doi.org/10.1016/j.bbacli.2016.04.007 Text en © 2016 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
de Laat, Paul
Janssen, Mirian C.H.
Alston, Charlotte L.
Taylor, Robert W.
Rodenburg, Richard J.T.
Smeitink, Jan A.M.
Three families with ‘de novo’ m.3243A > G mutation
title Three families with ‘de novo’ m.3243A > G mutation
title_full Three families with ‘de novo’ m.3243A > G mutation
title_fullStr Three families with ‘de novo’ m.3243A > G mutation
title_full_unstemmed Three families with ‘de novo’ m.3243A > G mutation
title_short Three families with ‘de novo’ m.3243A > G mutation
title_sort three families with ‘de novo’ m.3243a > g mutation
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900294/
https://www.ncbi.nlm.nih.gov/pubmed/27331024
http://dx.doi.org/10.1016/j.bbacli.2016.04.007
work_keys_str_mv AT delaatpaul threefamilieswithdenovom3243agmutation
AT janssenmirianch threefamilieswithdenovom3243agmutation
AT alstoncharlottel threefamilieswithdenovom3243agmutation
AT taylorrobertw threefamilieswithdenovom3243agmutation
AT rodenburgrichardjt threefamilieswithdenovom3243agmutation
AT smeitinkjanam threefamilieswithdenovom3243agmutation